Skip to main content
. 2022 Apr 11;13:803234. doi: 10.3389/fpsyt.2022.803234

TABLE 1.

Demographic and clinical characteristics of study sample.

CON (n = 60)
EOS (n = 28)
AOS (n = 33)
Statistic
Mean (SD) Mean (SD) Mean (SD) F-test df p
Age, mean (SD) 36.2 (13.9) 34.7 (14.0) 40.1 (11.7) 1.40 2,118 0.25
Age of illness onset, mean (SD) 13.8 (3.0) 22.2 (4.1) 81.73 1,60 <0.001
Duration of illness, mean (SD) 21.0 (14.1) 17.9 (12.5) 0.82 1,60 0.37
Cigarette use (cigarettes per year)* 1,389 (2,892) 4,404 (4,699) 5,065 (5,525) 9.98 2,119 <0.001
Antipsychotic medication use
1st-generation (Dose years) 0.3 (1.1) 3.0 (5.3) 7.36 1,60 0.009
2nd-generation (Dose years) 3.2 (2.9) 3.7 (3.6) 0.30 1,60 0.58
Cognition
Crystallized IQ 0.45 (0.87) −0.39 (1.0) −0.44 (0.77) 13.6 2,113 <0.001
Working memory 0.38 (0.63) −0.61 (0.67) −0.42 (0.55) 29.8 2,113 <0.001
Episodic memory 0.68 (0.66) −0.56 (0.74) −0.61 (0.64) 50.5 2,113 <0.001
Executive functioning 0.41 (0.49) −0.46 (0.76) −0.57 (0.77) 32.5 2,113 <0.001
Psychopathology
Positive symptoms 0.31 (0.82) 0.18 (0.84) 0.38 1,60 0.53
Negative symptoms 0.35 (0.66) 0.41 (0.64) 0.16 1,60 0.68
Disorganized symptoms 0.17 (0.67) 0.21 (0.56) 0.08 1,60 0.77

N (%) N (%) N (%) X 2 df p

Gender, No. (% male) 36 (60.0%) 17 (60.7%) 21 (63.6%) 0.12 2 0.94
SES class (Class 3) 25 (42.4%) 9 (40.95) 5 (17.2%) 13.56 8 0.94
Substance use disorder
Alcohol 9 (15.0%) 13 (46.4%) 13 (39.4%) 11.59 2 0.003
Cannabis 2 (3.3%) 15 (53.6%) 7 (21.2%) 30.35 2 <0.001
Cocaine 1 (1.7%) 9 (32.1%) 2 (6.1%) 20.60 2 <0.001
Opiates 1 (1.7%) 4 (14.3%) 1 (3.0%) 6.81 2 0.03
Hallucinogens 1 (1.7%) 4 (14.8%) 1 (3.0%) 7.14 2 0.28
Sedatives 1 (1.7%) 5 (18.5%) 2 (6.1%) 8.52 2 0.01
Stimulants 1 (1.7%) 1 (3.7%) 2 (6.1%) 1.29 2 0.52

*EOS > CON (p = 0.002); AOS > CON (p < 0.001).

EOS < CON (p < 0.001); AOS < CON (p < 0.001). Bold = p < 0.05 for the overall omnibus model.